Medpace Holdings, Inc. Common Stock
MEDPNASDAQIndustrials · Services-commercial Physical & Biological Research
Market cap
$11.86B
Employees
6,300
Exchange
NASDAQ
Headquarters
CINCINNATI, OH
About Medpace Holdings, Inc. Common Stock
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Industry
Services-commercial Physical & Biological Research
Sector
Industrials
Country
US
Website
www.medpace.comMEDP news
Law firm Glancy Prongay Wolke & Rotter LLP is urging Medpace Holdings shareholders who suffered losses to join a securities fraud lawsuit against the company. The firm is investigating potential misconduct and encouraging affected investors to contact them before the legal deadline expires. Shareholders with losses may be eligible for compensation through the class action suit.
GlobeNewswire Inc. · May 15, 2026
Law firm Bronstein, Gewirtz & Grossman has filed a class action lawsuit against Medpace Holdings, Inc., alleging investor harm. The firm is urging shareholders to take action and participate in the legal proceedings. This lawsuit represents an effort to recover damages for affected investors.
GlobeNewswire Inc. · May 15, 2026